Strategic Perspectives

Explore the latest resources, perspectives, and launch strategies from the TJP team.

340B Program, Explained: How Manufacturers Should Respond

The 340B program is a critical provision for the pharmaceutical industry, one that has now shaped...

For pharmaceutical companies, an effective patient access strategy starts with an in-depth...

Bringing a pharmaceutical product to market is more challenging than ever. Payers demand stronger...